Trial intelligence / Profile preview

Trimebutine for Postoperative Pain After Hemorrhoidectomy

NCT03036111Suspended

Sponsor
Mansoura University
Start
Feb 2017
Primary completion
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, triple-blind trial of trimebutine in postoperative pain (2 arms), sponsored by Mansoura University. Primary endpoint: Pain assessment using visual analogue score at 12 hours. Started Feb 2017; status: suspended.

02

Drugs

trimebutine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03036111.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03036111.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call